Myocardial infarction- RISK

Myocardial infarctions occur when blood flow to a part of the heart decreases or stops. Here is the latest research on factors and mechanisms that modulate the risk of myocardial infarctions.

September 12, 2020
Open Access

Risk prediction for coronary heart disease by a genetic risk score - results from the Heinz Nixdorf Recall study

BMC Medical Genetics
Sonali PechlivanisSusanne Moebus
August 17, 2020

A preprocedural risk score predicts acute kidney injury following primary percutaneous coronary intervention

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
Stefano BurattiGaetano M De Ferrari
August 3, 2020

Rotablation in the very elderly - Safer than we think?

Cardiovascular Revascularization Medicine : Including Molecular Interventions
Vinoda SharmaVivek Kodoth
August 25, 2020

State of the Art: Imaging for Myocardial Viability: A Scientific Statement From the American Heart Association

Circulation. Cardiovascular Imaging
Mario J GarciaAmerican Heart Association Council on Cardiovascular Radiology and Intervention and Council on Clinical Cardiology
August 1, 2020

New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
Harm WienbergenHarald Langer
July 29, 2020

Meta-analysis Comparing Transradial Versus Transfemoral Secondary Access in Transcatheter Aortic Valve Implantation

The American Journal of Cardiology
Aravdeep JhandAndrew M Goldsweig
July 31, 2020
Open Access

A practical risk score for early prediction of neurological outcome after out-of-hospital cardiac arrest: MIRACLE2

European Heart Journal
Nilesh PareekPhilip MacCarthy
August 29, 2020

Prognostic value of HbA1c and plasma glucose on one-year mortality in non-diabetic patients after myocardial infarction

Annales de cardiologie et d'angéiologie
E Gueniat-RatheauY Cottin
August 9, 2020
Open Access

The Summit Score Stratifies Mortality and Morbidity in Chronic Obstructive Pulmonary Disease

International Journal of Chronic Obstructive Pulmonary Disease
Benjamin D HorneDenitza P Blagev
September 18, 2020

Adherence to quality indicators for ST-elevation myocardial infarction and its relation to mortality: a hospital network analysis from the Belgian STEMI database

European Heart Journal. Quality of Care & Clinical Outcomes
Sara BosmansMarc J Claeys
September 8, 2020

Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connection

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Nikolaos KosmasEfstathios K Iliodromitis
September 21, 2020

Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure

Revista Española De Cardiología
Ramón C HermidaJosé R Fernández
August 9, 2020
Open Access

Sibling validation of polygenic risk scores and complex trait prediction

Scientific Reports
Louis LelloStephen D H Hsu
July 25, 2020
Open Access

Fragmented QRS complex frequency and location as predictor of cardiogenic shock and mortality following acute coronary syndrome

The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology
Ahmad Salah YounisNora Ismail Mohamed Abbas
September 17, 2020
Open Access

No-Reflow after PPCI-A Predictor of Short-Term Outcomes in STEMI Patients

Journal of Clinical Medicine
Larisa Renata Pantea-RoșanCamelia Cristina Diaconu

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

© 2020 Meta ULC. All rights reserved
/feed-previews/myocardial-infarction--risk/b5d92b8a-2b6e-43ce-91f8-952f94b59509